Highlights BioSig Technologies, Inc.

Equities

BSGM

US09073N3008

Delayed Nasdaq Other stock markets 14:35:58 13/05/2024 BST			5-day change	1st Jan Change
1.233 ^USD	-1.34%		-13.15%	-74.04%

05-03	BioSig Technologies, Inc. Announces Board Appointments	CI
05-01	BioSig Technologies, Inc. announced that it has received $1.144164 million in funding	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

BioSig Technologies, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	04-16	CI
BioSig Technologies, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-14	CI
Mayo Clinic-Phoenix Adopts Biosig Technologies, Inc.'s New Pure EP Subscription Model	11-02	CI
Biosig Technologies, Inc. Enters into an Agreement with Sb Technology, Inc	05/09/23	CI
BioSig Technologies, Inc. Achieves Infrastructure and Technology Progress in Development of Generative AI Platform for Hospitals	24/08/23	CI
Biosig Technologies, Inc. Introduces New Subscription Model for Pure Ep? Platform, Offering Quicker Access to Latest Features, Customers	23/08/23	CI
Biosig Technologies, Inc.'s Pure Ep Platform Debuts New Automated Features in First Patient Cases	22/08/23	CI
BioSig Technologies, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	14/08/23	CI
BioSig Technologies, Inc. Advances Collaboration on Machine Learning and Artificial Intelligence Solutions for Healthcare	27/06/23	CI
BioSig Technologies, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	15/05/23	CI
BioSig Technologies, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	31/03/23	CI
BioSig Technologies Gets US Patent for Universal Notch Filter Technology	17/02/23	MT
BioSig's PURE EP(TM) System Demonstrates Potential Time and Cost Savings At the 15th APHRS Scientific Session in Singapore	14/12/22	CI
BioSig Technologies, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	14/11/22	CI
BioSig Signs Master Research Agreement with Cleveland Clinic to Explore Expanded Applications for Its Digital Signal Processing Technology	24/10/22	CI
BioSig Technologies Signs Digital Signal Processing Research Deal With Cleveland Clinic; Shares Down Midday	24/10/22	MT
The Methodist Hospital acquired PURE EP(TM) System from BioSig Technologies, Inc..	06/10/22	CI
BioSig Technologies, Inc. Launches PURE EP™ Software Version 6 with ACCUVIZ™ Module	22/09/22	CI
BioSig Technologies, Inc Places Second PURE EP™ System For Evaluation at Cleveland Clinic a Leading Medical Center of Excellence	24/08/22	CI
BioSig Technologies, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	15/08/22	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights BioSig Technologies, Inc.

Equities

BSGM

US09073N3008

Highlights

Filters